Abstract
In chronic obstructive pulmonary disease (COPD), cognitive dysfunction - mainly of secondary memory, executive, and constructional abilities - is a marker of disease severity with important clinical and prognostic implications. It correlates with poor compliance with pharmacological therapy, and poor compliance, in turn, increases the cost/effectiveness ratio of home care programs. Executive dysfunction is associated with difficulty with inhaler devices and should be systematically evaluated before prescribing. Drawing impairment has been associated with mortality, although the underlying neurologic abnormalities (right insular damage with autonomic dysfunction or subcortical damage) remain to be defined. Depression is also negatively correlated with survival, besides being a risk factor for quitting respiratory rehabilitation. Cognitive dysfunction should always be considered among the systemic effects of COPD and be the object of systematic screening in COPD patients. Identifying cognitive impairment would prompt either interventions promoting the adherence to the therapy or further investigations to exclude respiratory (nocturnal or effort hypoxemia, coexistent obstructive sleep apnoea) or non respiratory (decompensated diabetes, hypoglycaemic crises, poorly controlled hypertension etc.) causes of cognitive dysfunction. Cognitive enhancing strategies deserve consideration in the framework of a comprehensive approach aimed at improving the health status of people with COPD.
Keywords: Cognitive impairment, depression, chronic obstructive pulmonary disease
Current Respiratory Medicine Reviews
Title: Clinical and Prognostic Implications of Cognitive Dysfunction and Depression in COPD
Volume: 3 Issue: 2
Author(s): Andrea Corsonello, Claudio Pedone and Raffaele Antonelli Incalzi
Affiliation:
Keywords: Cognitive impairment, depression, chronic obstructive pulmonary disease
Abstract: In chronic obstructive pulmonary disease (COPD), cognitive dysfunction - mainly of secondary memory, executive, and constructional abilities - is a marker of disease severity with important clinical and prognostic implications. It correlates with poor compliance with pharmacological therapy, and poor compliance, in turn, increases the cost/effectiveness ratio of home care programs. Executive dysfunction is associated with difficulty with inhaler devices and should be systematically evaluated before prescribing. Drawing impairment has been associated with mortality, although the underlying neurologic abnormalities (right insular damage with autonomic dysfunction or subcortical damage) remain to be defined. Depression is also negatively correlated with survival, besides being a risk factor for quitting respiratory rehabilitation. Cognitive dysfunction should always be considered among the systemic effects of COPD and be the object of systematic screening in COPD patients. Identifying cognitive impairment would prompt either interventions promoting the adherence to the therapy or further investigations to exclude respiratory (nocturnal or effort hypoxemia, coexistent obstructive sleep apnoea) or non respiratory (decompensated diabetes, hypoglycaemic crises, poorly controlled hypertension etc.) causes of cognitive dysfunction. Cognitive enhancing strategies deserve consideration in the framework of a comprehensive approach aimed at improving the health status of people with COPD.
Export Options
About this article
Cite this article as:
Corsonello Andrea, Pedone Claudio and Antonelli Incalzi Raffaele, Clinical and Prognostic Implications of Cognitive Dysfunction and Depression in COPD, Current Respiratory Medicine Reviews 2007; 3 (2) . https://dx.doi.org/10.2174/157339807780599162
DOI https://dx.doi.org/10.2174/157339807780599162 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antioxidant Response of Osteoblasts to Doxycycline in an Inflammatory Model Induced by C-reactive Protein and Interleukin-6
Infectious Disorders - Drug Targets Mandatory Reporting of Coronary Artery Calcifications Incidentally Noted on Chest Multi-Detector Computed Tomography: A Multicentre Experience
Current Vascular Pharmacology Peripartum Cardiomyopathy: Current State of Knowledge, New Developments and Future Directions
Current Cardiology Reviews Diagnosis and Management of Endocrine Hypertension in Children and Adolescents
Current Pharmaceutical Design Decrease of Risk of Developing Symptoms of OAB in Elderly Men and Women Treated with Loop Diuretic for Hypertensive Disease Using Solifenacin
Current Aging Science Uric Acid and Hypertension
Current Pharmaceutical Design Exploring New CGRP Family Peptides and their Receptors in Vertebrates
Current Protein & Peptide Science Vasopressin in Liver Disease – Should We Turn On or Off?
Current Clinical Pharmacology Brainstem Neuropeptides and Vagal Protection of the Gastric Mucosal Against Injury: Role of Prostaglandins, Nitric Oxide and Calcitonin-Gene Related Peptide in Capsaicin Afferents
Current Medicinal Chemistry Diversity in Hypertension and Cardiovascular Disease Around the Globe
Current Hypertension Reviews Synthesis and Biological Evaluations of Novel Nitric Oxide-donating Derivatives of [1,2,4]triazol-5(4H)-one with N-phenylpyrrolyl-2-tetrazole Moiety as Anti-hypertension Candidates
Letters in Drug Design & Discovery The Relationship between Age-Related Kidney Dysfunction and Framingham Risk Score in Healthy People in China
Current Aging Science Mechanical Ventilation Following Cardiac Surgery in Children
Current Respiratory Medicine Reviews Is Kidney Stone Associated with Thyroid Disease? The United States National Health and Nutrition Examination Survey 2007-2018
Endocrine, Metabolic & Immune Disorders - Drug Targets Fibrosis, Enzymatic and Non-Enzymatic Cross-Links in Hypertensive Heart Disease
Cardiovascular & Hematological Disorders-Drug Targets Magnesium Lithospermate B Extracted from Salvia Miltiorrhiza, A Potential Substitute for Cardiac Glycosides
Mini-Reviews in Organic Chemistry The Role on Endoscopy in Alcohol-Related Diseases
Reviews on Recent Clinical Trials Neuroprotective Effects of Estrogens: Cross-Talk Between Estrogen and Intracellular Insulin Signalling
Infectious Disorders - Drug Targets NPY and Cardiac Diseases
Current Topics in Medicinal Chemistry Difference in the Influence of the Lipid Profile as a Coronary Risk Factor in Patients with and Without Diabetes Mellitus
Vascular Disease Prevention (Discontinued)